Articles

Express Scripts-Medco deal approved by U.S. regulators

Express Scripts Inc.’s $29.1 billion bid for rival drug benefit manager Medco Health Solutions Inc. won unconditional approval from U.S. antitrust regulators, clearing the way to create the biggest manager of prescription-drug benefits for corporate and government clients.

Read More

Past support of health care mandate haunts Lugar

Like many Senate Republicans who have spent a few decades in Washington, U.S. Sen. Richard Lugar was for the individual health care mandate before he was against it. Two decades later, the policy is a near heretical stance among the party’s conservative base, and it threatens to derail Lugar’s reelection bid.

Read More

Carmel man charged with defrauding Medicaid of $1M

Businessman Donald Hamilton faces one count of health care fraud, five counts of false statements in a health care matter and two counts of money laundering. He faces a maximum sentence of 55 years if convicted on all counts.

Read More

Indy lab company secures $30M seed investment

Indianapolis-based Strand Diagnostics LLC will receive up to $30 million in investment capital over the next three years from Los Angeles-based NantWorks LLC, a seed-stage investment firm, the companies announced this week.

Read More

Community to expand Heart Hospital

Community Health Network will break ground this month on a $6.9 million, 4,600-square-foot expansion of its Indiana Heart Hospital, adding two operating rooms.

Read More

FTC asks critics of Express Scripts-Medco deal for ideas

Two pharmacy groups opposing Express Scripts Inc.’s proposed acquisition of Medco Health Solutions Inc. said they were asked by the U.S. Federal Trade Commission to suggest ways to revise the $29.1 billion deal so it wouldn’t harm competition.

Read More

Lilly to try again to remove poison-pill provisions

Eli Lilly and Co.’s board is once again recommending the removal of a provision that makes the company an almost impossible target for hostile takeovers. The same proposal has fallen slightly short at each of the past two annual shareholder meetings.

Read More

Arcadia: Don’t buy our stock

Arcadia Resources Inc. is telling shareholders not to buy its stock because it is out of cash and faces a $40 million pile of debt that comes due on April 1.

Read More

Franciscan pulls back Greenwood plans

Franciscan St. Francis Health said its plans to build an emergency room and physician office building in Greenwood are on hold due to uncertainty over the effects of health care reform.

Read More

Lilly settles Zyprexa marketing suit for $1.4 billion

Indianapolis-based Lilly pleaded guilty to one violation of the Food, Drug and Cosmetic Act on Thursday and agreed to pay $1.42 billion to settle both that criminal charge as well as civil lawsuits in which it did not admit wrongdoing.

Read More